1. Dose-response curves after in vivo experimental chemotherapy: Influence of rouze of administration on biological outcomes

   • James V. Moore

   Editorial Pages: 91 - 92

2. The effect of cisplatin on renal ATPase activity in vivo and in vitro

   • Jiro Uozumi
   • Charles L. Litterst

   Original Articles Pages: 93 - 96

3. Phase I study of the cisplatin analogue 1,1-diamminomethylcyclohexane sulfatoplatinum (TNO-6) (NSC 311056)

   • J. B. Sørensen
   • S. Groth
   • H. H. Hansen

   Original Articles Pages: 97 - 100

4. Kinetics of 7-hydroxy-methotrexate after high-dose methotrexate therapy

   • R. Erttmann
   • S. Bielack
   • G. Landbeck

   Original Articles Pages: 101 - 104

5. Differential calcium leucovorin protection of human lymphoid cell lines from methotrexate

   • George P. Browman
   • Lynda Booker
   • Paula Spiegl

   Original Articles Pages: 105 - 110

6. Comparison of leucovorin protection from variety of antifolates in human lymphoid cell lines

   • George P. Browman
   • Paula Spiegl
   • Andre Rosowsky

   Original Articles Pages: 111 - 114

7. Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate in rabbits

   • Heiko Iven
   • Helmut Brasch
   • Jörg Engster

   Original Articles Pages: 115 - 120

8. Drug monitoring of etoposide (VP16-213)

   • Harald Danigel
   • Karl-Heinz Pflüger
   • Jörg Dellbrügge

   Original Articles Pages: 121 - 124

9. Effects of amino acids on the transport and cytotoxicity of melphalan by human bone marrow cells and human tumor cells

   • Maurice Dufour
   • Lawrence C. Panasci
   • Louise Boulet

   Original Articles Pages: 125 - 131

10. Pharmacokinetics and disposition of 4′-O-tetrahydropyranyladriamycin in mice by HPLC analysis

    • Hiroshi Iguchi
    • Hiroshi Tone
    • Hamao Umezawa

    Original Articles Pages: 132 - 140

11. The effects of arotinoids on rat mammary carcinogenesis

    • Hans-Rudolf Hartmann
    • Werner Bollag

    Original Articles Pages: 141 - 143

12. A phase I and pharmacokinetic comparison of hepatic arterial and peripheral vein infusions of bisantrene for liver cancer

    • Geoffrey R. Weiss
    • Marla Hersh
    • Thomas E. Pirtle III

    Original Articles Pages: 144 - 148

13. Pharmacokinetics of teniposide (VM 26) after IV administration in serum and malignant ascites of patients with ovarian carcinoma

    • P. Canal
    • R. Bugat
    • P. F. Combes

    Original Articles Pages: 149 - 152

14. Comparative murine metabolism and disposition of class II anthracycline antibiotics

    • Pierre Dodion
    • Merrill J Egorin
    • Nicholas R. Bachur

    Original Articles Pages: 153 - 160

15. Doxifluridine (5′-dFUrd) in patients with advanced colorectal carcinoma

    • Sophie D. Fosså
    • Olav Dahl
    • Mitchell Loeb

    Original Articles Pages: 161 - 163

16. A phase II study of sequential methotrexate and fluorouracil in advanced colorectal cancer

    • L. Panasci
    • J. Ford
    • R. Margolese

    Original Articles Pages: 164 - 166

17. Mechanism of adrenal suppression by high-dose medroxyprogesterone acetate in breast cancer patients

    • H. van Veelen
    • P. H. B. Willemse
    • H. Doorenbos

    Original Articles Pages: 167 - 170

18. The treatment of postmenopausal women with advanced breast cancer with buserelin

    • J. H. Waxman
    • S. J. Harland
    • T. A. Lister

    Original Articles Pages: 171 - 173

19. Nephrotoxicity of lomustine

    • Mark E. Ellis
    • Raymond B. Weiss
    • Mario Kuperminc

    Original Articles Pages: 174 - 175

20. High-performance liquid chromatographic assay for simultaneous estimation of aminoglutethimide and acethylamidoglutethimide in biological fluids

    • Adam M. Adam
    • Ian D. Bradbrook
    • Howard J. Rogers

    Short Communication Pages: 176 - 178

21. Cisplatin, adriamycin and cyclophosphamide (PACe) combination chemotherapy in patients with ovarian carcinoma resistant to chlorambucil

    • Graham M. Mead
    • Christopher J. Williams
    • J. Michael Whitehouse

    Short Communication Pages: 179 - 180

22. Phase II study of a combination of mitomycin, doxorubicin and cisplatin in advanced sarcomas

    • John H. Edmonson
    • Harry J. Long
    • Stephanie J. Green

    Short Communication Pages: 181 - 182

23. Concerning the paper Clinical pharmacology of high-dose cisplatin by Corden et al.

    • Michael W. DeGregorio
    • Jordan R. Wilbur
    • Brian J. Corden

    Letter to the Editor Pages: 183 - 184

24. Meeting announcements

    Announcement Pages: i - i